SCHEMBL13060693

SCHEMBL13060693

CCc1cccc(CN(CCN(C)C)Cc2ccccc2Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.48
CAMKK2 Q96RR4 1/20 0.48
TAAR1 Q96RJ0 2/20 0.46
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
HPGD P15428 1/20 0.39
PYCR1 P32322 1/20 0.39
AOC3 Q16853 1/20 0.38
RORC P51449 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061030 0.86 CALM1 (0.47) CALM1CAMKK2TAAR1KDM4EALDH1A1
SCHEMBL13005661 0.86 CALM1 (0.45) CALM1CAMKK2TAAR1KDM4EALDH1A1
SCHEMBL4818525 0.86 TAAR1 (0.54) CALM1CAMKK2TAAR1KDM4EALDH1A1
SCHEMBL13060704 0.85 CALM1 (0.49) CALM1CAMKK2KDM4EALDH1A1TSHR
SCHEMBL13061102 0.84 CALM1 (0.64) CALM1CAMKK2TAAR1KDM4EALDH1A1
SCHEMBL13061136 0.84 CALM1 (0.48) CALM1CAMKK2TAAR1KDM4EALDH1A1
SCHEMBL13061026 0.83 TAAR1 (0.57) CALM1CAMKK2TAAR1TSHRPYCR1
SCHEMBL13061031 0.83 CYP2D6 (0.49) CALM1CAMKK2KDM4EALDH1A1TSHR
SCHEMBL13061083 0.82 CALM1 (0.49) CALM1CAMKK2KDM4EALDH1A1TSHR
SCHEMBL13060703 0.81 CALM1 (0.45) CALM1CAMKK2KDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed